Mirtazapine

Mirtazapine is a tetracyclic antidepressant used in the treatment of major depression and is used off-label as a drug for insomnia and to increase appetite. Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.

Chemical structure of Mirtazapine
Mechanism
Curator reviewed · 6 references
Primary indication
This drug is indicated for the treatment of major depressive disorder and its associated symptoms.Curator reviewed · 15 structured indications
Formula / weight
C17H19N3 · 265.3529 g/mol (avg)
First approval
Canada, 2004 · United States, 1996
Also known as
6-Azamianserin · Mepirzapine
Code names
Org 3770
Brand names
  • Remeron

Resolves to

Structure
InChIKeyRONZAEMNMFQXRA-UHFFFAOYSA-NSMILESCN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Transporters

What you can answer from here — as of September 23, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,904Drug interactionsStructured to mechanism, not free text
Sign in
105Clinical trialsPhase, status and sponsor resolved per trial
Sign in
15Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
1,666Marketed productsAcross 11 countries and 148 labellers
Sign in
1ATC codeIncluding every combination product, plus 43 drug categories
Sign in
85+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mirtazapine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account